H Morbach

Summary

Country: Germany

Publications

  1. pmc Treatment of Lyme borreliosis
    Hermann J Girschick
    Paediatric Rheumatology, Immunology, Osteology and Infectious Diseases, Children s Hospital, University of Wuerzburg, Josef Schneider Str, 2, 97080 Wuerzburg, Germany
    Arthritis Res Ther 11:258. 2009
  2. pmc Chronic nonbacterial osteomyelitis in childhood: prospective follow-up during the first year of anti-inflammatory treatment
    Christine Beck
    Children s Hospital, Section of Paediatric Rheumatology, Osteology, Immunology and Infectious Diseases, University of Wurzburg, Josef Schneider Strasse 2, 97080 Wurzburg, Germany
    Arthritis Res Ther 12:R74. 2010
  3. ncbi request reprint Do B cells play a role in the pathogenesis of juvenile idiopathic arthritis?
    H Morbach
    Pediatric Rheumatology, Immunology and Infectious Diseases, Children s Hospital, University of Wurzburg, Wurzburg, Germany
    Autoimmunity 42:373-5. 2009
  4. doi request reprint Tumor necrosis factor receptor 1-associated periodic syndrome without fever: cytokine profile before and during etanercept treatment
    H Morbach
    Section of pediatric rheumatology and osteology, Children s Hospital, University of Wurzburg, Josef Schneider Str 2, 97080 Wurzburg, Germany
    Rheumatol Int 30:207-12. 2009
  5. doi request reprint How can calcium pyrophosphate crystals induce inflammation in hypophosphatasia or chronic inflammatory joint diseases?
    C Beck
    Children s Hospital, Section of Pediatric Rheumatology, Immunology and Infectious Diseases, University of Wurzburg, Josef Schneider Str 2, 97090, Wurzburg, Germany
    Rheumatol Int 29:229-38. 2009
  6. doi request reprint Whole-body MRI in the childhood form of hypophosphatasia
    C Beck
    Section of Pediatric Rheumatology, Osteology, Immunology and Infectious Diseases, Children s Hospital, University of Wurzburg, Josef Schneider Strasse 2, 97080, Wurzburg, Germany
    Rheumatol Int 31:1315-20. 2011
  7. doi request reprint Crohn's disease during etanercept therapy in juvenile idiopathic arthritis: a case report and review of the literature
    V Wiegering
    Pediatric Rheumatology, Immunology, Gastroenterology and Infectious Diseases, Children s Hospital, University of Wurzburg, Josef Schneider Str 2, 97080, Wurzburg, Germany
    Rheumatol Int 30:801-4. 2010
  8. pmc Reference values for B cell subpopulations from infancy to adulthood
    H Morbach
    Department of Pediatrics, University of Wurzburg, Germany
    Clin Exp Immunol 162:271-9. 2010
  9. pmc Differential expression patterns of recombination-activating genes in individual mature B cells in juvenile idiopathic arthritis
    C Faber
    Section of Paediatric Rheumatology and Osteology, Children s Hospital, University of Wurzburg, Josef Schneider Str 2, D 97080 Wurzburg, Germany
    Ann Rheum Dis 65:1351-6. 2006
  10. pmc B-cell pathology in juvenile idiopathic arthritis
    V Wiegering
    Pediatric Hematology, Oncology and Neurooncology, Pediatric Stem Cell Transplantation Program, Children s Hospital, University of Wurzburg, Josef Schneider Str 2, 97080 Wurzburg, Germany
    Arthritis 2010:759868. 2010

Detail Information

Publications11

  1. pmc Treatment of Lyme borreliosis
    Hermann J Girschick
    Paediatric Rheumatology, Immunology, Osteology and Infectious Diseases, Children s Hospital, University of Wuerzburg, Josef Schneider Str, 2, 97080 Wuerzburg, Germany
    Arthritis Res Ther 11:258. 2009
    ..If the infection is manifest, then treatment strategies should target not only the pathogen by using antibiotics but also the chronic inflammation by using anti-inflammatory drugs...
  2. pmc Chronic nonbacterial osteomyelitis in childhood: prospective follow-up during the first year of anti-inflammatory treatment
    Christine Beck
    Children s Hospital, Section of Paediatric Rheumatology, Osteology, Immunology and Infectious Diseases, University of Wurzburg, Josef Schneider Strasse 2, 97080 Wurzburg, Germany
    Arthritis Res Ther 12:R74. 2010
    ..Prospectively followed cohorts using a standardized protocol in diagnosis and treatment have rarely been reported...
  3. ncbi request reprint Do B cells play a role in the pathogenesis of juvenile idiopathic arthritis?
    H Morbach
    Pediatric Rheumatology, Immunology and Infectious Diseases, Children s Hospital, University of Wurzburg, Wurzburg, Germany
    Autoimmunity 42:373-5. 2009
    ..We discuss whether BC play a role in the pathogenesis of JIA appraising the question for an immunological basis of BC directed therapy...
  4. doi request reprint Tumor necrosis factor receptor 1-associated periodic syndrome without fever: cytokine profile before and during etanercept treatment
    H Morbach
    Section of pediatric rheumatology and osteology, Children s Hospital, University of Wurzburg, Josef Schneider Str 2, 97080 Wurzburg, Germany
    Rheumatol Int 30:207-12. 2009
    ..Hereditary fever syndromes have to be considered in case of chronic unexplained inflammation even if fever is no presenting symptom...
  5. doi request reprint How can calcium pyrophosphate crystals induce inflammation in hypophosphatasia or chronic inflammatory joint diseases?
    C Beck
    Children s Hospital, Section of Pediatric Rheumatology, Immunology and Infectious Diseases, University of Wurzburg, Josef Schneider Str 2, 97090, Wurzburg, Germany
    Rheumatol Int 29:229-38. 2009
    ..They might support the development of new therapeutic strategies for crystal-induced inflammation. Eventually, patients with HP might as well profit from such strategies addressing these metabolic disorders secondary to the gene defect...
  6. doi request reprint Whole-body MRI in the childhood form of hypophosphatasia
    C Beck
    Section of Pediatric Rheumatology, Osteology, Immunology and Infectious Diseases, Children s Hospital, University of Wurzburg, Josef Schneider Strasse 2, 97080, Wurzburg, Germany
    Rheumatol Int 31:1315-20. 2011
    ..Differential diagnosis includes an inflammatory process being active in these locations...
  7. doi request reprint Crohn's disease during etanercept therapy in juvenile idiopathic arthritis: a case report and review of the literature
    V Wiegering
    Pediatric Rheumatology, Immunology, Gastroenterology and Infectious Diseases, Children s Hospital, University of Wurzburg, Josef Schneider Str 2, 97080, Wurzburg, Germany
    Rheumatol Int 30:801-4. 2010
    ..This case indicates that immunodysregulatory and even proinflammatory effects of etanercept are of relevance in the clinical practice. Furthermore, TNFalpha as a part of its function seems to downregulate mucosal inflammation in CD...
  8. pmc Reference values for B cell subpopulations from infancy to adulthood
    H Morbach
    Department of Pediatrics, University of Wurzburg, Germany
    Clin Exp Immunol 162:271-9. 2010
    ....
  9. pmc Differential expression patterns of recombination-activating genes in individual mature B cells in juvenile idiopathic arthritis
    C Faber
    Section of Paediatric Rheumatology and Osteology, Children s Hospital, University of Wurzburg, Josef Schneider Str 2, D 97080 Wurzburg, Germany
    Ann Rheum Dis 65:1351-6. 2006
    ..The presence of antinuclear antibodies (ANA) as a hallmark of oligoarticular juvenile idiopathic arthritis (o-JIA, early-onset type) indicates a breakdown in immunological tolerance...
  10. pmc B-cell pathology in juvenile idiopathic arthritis
    V Wiegering
    Pediatric Hematology, Oncology and Neurooncology, Pediatric Stem Cell Transplantation Program, Children s Hospital, University of Wurzburg, Josef Schneider Str 2, 97080 Wurzburg, Germany
    Arthritis 2010:759868. 2010
    ..In this review we will discuss the importance of B-cells in the pathogenesis of JIA appraising the question for an immunological basis of B-cell targeted therapy in JIA...
  11. doi request reprint [Hypophosphatasia]
    C Beck
    Bereiche Immunologie, Infektiologie, Hämostasiologie, Rheumatologie, Osteologie und Gastroenterologie, Kinderklinik und Poliklinik des Universitätsklinikums, Julius Maximilians Universitat Wurzburg, Wurzburg, Germany
    Klin Padiatr 221:219-26. 2009
    ..At the moment symptomatic support and treatment is most important because a causative therapy, e. g. enzyme replacement therapy, is not yet available...